Literature DB >> 18844840

Vitamin D and multiple sclerosis: an update.

Margherita T Cantorna1.   

Abstract

Observational studies document a positive relationship between vitamin D from the environment (sunlight or diet), circulating vitamin D status, and improved symptoms or prevention of multiple sclerosis (MS). Experimental animal models of MS reproduce the beneficial effects of vitamin D and 1,25(OH)(2)D(3). The geographical distribution of MS can be explained by both the hygiene hypothesis and the vitamin D hypothesis. It therefore seems more likely that both hypotheses may be correct and that there are interactions between multiple environmental factors like vitamin D and the rate of infection that might explain the etiology of MS. The effects of vitamin D on the immune system and in the CNS have begun to be described and there is some information on the mechanisms underlying the effects of vitamin D in MS. A need exists for better understanding of the interactions of the environmental factors on MS, communication with the physicians treating MS patients as to the benefits of vitamin D, and clinical interventions with both vitamin D and analogs of 1,25(OH)(2)D(3).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18844840      PMCID: PMC3712128          DOI: 10.1111/j.1753-4887.2008.00097.x

Source DB:  PubMed          Journal:  Nutr Rev        ISSN: 0029-6643            Impact factor:   7.110


  19 in total

Review 1.  The role of genetic factors in multiple sclerosis susceptibility.

Authors:  G C Ebers; A D Sadovnick
Journal:  J Neuroimmunol       Date:  1994-10       Impact factor: 3.478

2.  Comparative epidemiology of multiple sclerosis and dental caries.

Authors:  W Craelius
Journal:  J Epidemiol Community Health (1978)       Date:  1978-09

3.  Annual incidence, prevalence, and mortality of multiple sclerosis in white South-African-born and in white immigrants to South Africa.

Authors:  G Dean
Journal:  Br Med J       Date:  1967-06-17

4.  Effect of dietary advice and n-3 supplementation in newly diagnosed MS patients.

Authors:  I Nordvik; K M Myhr; H Nyland; K S Bjerve
Journal:  Acta Neurol Scand       Date:  2000-09       Impact factor: 3.209

5.  1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis.

Authors:  M T Cantorna; C E Hayes; H F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

Review 6.  Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence.

Authors:  Margherita T Cantorna; Brett D Mahon
Journal:  Exp Biol Med (Maywood)       Date:  2004-12

7.  Vitamin D deficiency and reduced bone mineral density in multiple sclerosis: effect of ambulatory status and functional capacity.

Authors:  Salih Ozgocmen; Serpil Bulut; Nevin Ilhan; Arif Gulkesen; Ozge Ardicoglu; Yusuf Ozkan
Journal:  J Bone Miner Metab       Date:  2005       Impact factor: 2.626

8.  Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D.

Authors:  P Goldberg; M C Fleming; E H Picard
Journal:  Med Hypotheses       Date:  1986-10       Impact factor: 1.538

9.  High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis.

Authors:  J Nieves; F Cosman; J Herbert; V Shen; R Lindsay
Journal:  Neurology       Date:  1994-09       Impact factor: 9.910

10.  Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia.

Authors:  I A F van der Mei; A-L Ponsonby; T Dwyer; L Blizzard; B V Taylor; T Kilpatrick; H Butzkueven; A J McMichael
Journal:  J Neurol       Date:  2007-04-11       Impact factor: 4.849

View more
  28 in total

Review 1.  Genetics and pathogenesis of multiple sclerosis.

Authors:  R L Zuvich; J L McCauley; M A Pericak-Vance; J L Haines
Journal:  Semin Immunol       Date:  2009-09-22       Impact factor: 11.130

2.  Vitamin D deficiency in mice impairs colonic antibacterial activity and predisposes to colitis.

Authors:  Venu Lagishetty; Alexander V Misharin; Nancy Q Liu; Thomas S Lisse; Rene F Chun; Yi Ouyang; Sandra M McLachlan; John S Adams; Martin Hewison
Journal:  Endocrinology       Date:  2010-04-14       Impact factor: 4.736

Review 3.  Vitamin D, multiple sclerosis and inflammatory bowel disease.

Authors:  Margherita T Cantorna
Journal:  Arch Biochem Biophys       Date:  2011-11-10       Impact factor: 4.013

Review 4.  Role of vitamin D in immune responses and autoimmune diseases, with emphasis on its role in multiple sclerosis.

Authors:  Hong-Liang Zhang; Jiang Wu
Journal:  Neurosci Bull       Date:  2010-12       Impact factor: 5.203

Review 5.  Why do T cells express the vitamin D receptor?

Authors:  Margherita T Cantorna
Journal:  Ann N Y Acad Sci       Date:  2010-11-29       Impact factor: 5.691

6.  The prevalence of multiple sclerosis in 3 US communities: the role of vitamin D.

Authors:  William B Grant
Journal:  Prev Chronic Dis       Date:  2010-06-15       Impact factor: 2.830

7.  Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis.

Authors:  Charles Pierrot-Deseilligny; Jean-Claude Souberbielle
Journal:  Ther Adv Neurol Disord       Date:  2013-03       Impact factor: 6.570

8.  Impaired T cell activation and cytokine production by calcitriol-primed human B cells.

Authors:  G Drozdenko; T Scheel; G Heine; R Baumgrass; M Worm
Journal:  Clin Exp Immunol       Date:  2014-11       Impact factor: 4.330

Review 9.  Combination treatment with progesterone and vitamin D hormone may be more effective than monotherapy for nervous system injury and disease.

Authors:  Milos Cekic; Iqbal Sayeed; Donald G Stein
Journal:  Front Neuroendocrinol       Date:  2009-04-24       Impact factor: 8.606

Review 10.  Clinical implications of a possible role of vitamin D in multiple sclerosis.

Authors:  Charles Pierrot-Deseilligny
Journal:  J Neurol       Date:  2009-04-28       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.